Inspira Technologies (IINN, Financial) has announced a significant breakthrough in the development of its VORTX(TM) technology following successful in-vivo tests. The innovative system is aimed at improving blood oxygenation while minimizing the trauma typically associated with traditional hollow fiber methods.
During the testing phase, VORTX achieved an impressive gas exchange efficiency, exceeding 99% at a specific flow rate. This accomplishment highlights the potential of the technology to advance significantly in the field of blood oxygenation solutions.
The achievement was completed under the support of an Israel Innovation Authority (IIA) funded framework, which further demonstrates Inspira Technologies' prowess in pioneering life-support technologies. The milestone marks a promising step forward in the company's ongoing efforts to enhance patient care through advanced medical innovations.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 1 analysts, the average target price for Inspira Technologies Oxy BHN Ltd (IINN, Financial) is $13.00 with a high estimate of $13.00 and a low estimate of $13.00. The average target implies an upside of 2,160.87% from the current price of $0.58. More detailed estimate data can be found on the Inspira Technologies Oxy BHN Ltd (IINN) Forecast page.
Based on the consensus recommendation from 1 brokerage firms, Inspira Technologies Oxy BHN Ltd's (IINN, Financial) average brokerage recommendation is currently 2.0, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
